U.S. Federal Court blocks Lupin, Zydus Life from bringing generic Myrbetriq to marketAstellas Pharma's Myrbetriq is used to treat overactive bladder and neurogenic detrusor overactivity. Surescripts Health Information Network achieves QHIN designationSurescripts Health Information Network can now provide access to nationwide health data exchange. The Alliance to End Hunger joins NACDS’ Nourish My Health campaign The campaign highlights nutrition’s essential role in supporting overall health and wellness. Morris & Dickson partners with Mark Cuban Cost Plus Drugs The partnership aims to mitigate drug shortages, democratize access, enhance flexibility and streamline procurement. AAM comments on Section 232 investigation on pharmaceuticals AAM said tariffs will exacerbate drug shortages that hinder patient access today. CVS may close stores in Arkansas following law banning PBMs from owning pharmacies HB1150 prohibits state permits to pharmacies owned by pharmacy benefit managers effective Jan. 1, 2026. President Trump signs executive order to lower Rx prices The order directs the Department of Health and Human Services to take steps to significantly reduce drug prices for American patients. FDA grants interchangeable designation for Celltrion’s Yuflyma Yuflyma is a high-concentration and citrate-free formulation of Humira biosimilar, approved for multiple inflammatory indications. Biocon Biologics secures market entry date for Eylea biosimilar Yesafili, a vascular endothelial growth factor inhibitor, is used to treat several different types of ophthalmology conditions and is a biosimilar of its Eylea. 21 students to receive CVS Health/AACP Community Pharmacy Award The scholarships will help reduce financial barriers for student pharmacists. First Previous 5 6 7 8 9 Next Last
